Prostate specific membrane antigen (PSMA) and Prostate Cancer Staging: is our current conventional staging obsolete?
Int Braz J Urol
.
2021 Nov-Dec;47(6):1243-1249.
doi: 10.1590/S1677-5538.IBJU.2020.0997.
Authors
Melissa Segura Céspedes
1
,
Jan Philipp Radtke
2
3
4
,
Xavier Cathelineau
4
,
Rafael Sanchez-Salas
5
Affiliations
1
Department of Urology, Klinikum Darmstadt, Darmstadt, Germany.
2
Department of Urology, University Hospital Essen, Essen, Germany.
3
German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
4
Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
5
Department of Urology, L`Institut Mutualiste Montsouris, Paris, France.
PMID:
33861056
PMCID:
PMC8486444
DOI:
10.1590/S1677-5538.IBJU.2020.0997
No abstract available
Publication types
Editorial
MeSH terms
Humans
Male
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Prostate-Specific Antigen
Prostatic Neoplasms* / pathology
Substances
Prostate-Specific Antigen